Six things to know:
1. Fourth quarter net sales were $1.8 billion, a 2.7 percent increase year-over-year. Full year sales for 2022 were $6.9 billion, a 1.6 percent increase from 2021.
2. While the company posted a net loss in the fourth quarter, net earnings for all of 2022 were $290.2 million.
3. Fourth quarter knee sales were $753.6 million, a 4.7 percent increase year-over-year. Hip sales of $488.7 million were a 1.7 percent increase from the same time last year.
4. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic busineses grew 3.3 percent year-over-year with $424.2 million in the fourth quarter.
5. Knee sales in 2022 raked in $2.8 billion, a 4.9 percent increase from 2021. Hip sales were $1.9 billion, a 2.1 percent increase.
6. Zimmer Biomet expects 2023 revenue to grow 1.5 percent to 3.5 percent.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
